Autres langues Aptamer Group PLC

Actions

APTA

GB00BNRRP542

Equipement et technologie médicale avancés

Marché Fermé - London S.E. 17:35:29 30/09/2026			Varia. 5j.	Varia. 1 janv.
0,3150 ^GBX	0,00%		-3,08%	-70,70%

19/08	PALMARÈS : Defence Holdings réduit ses pertes et s'explique sur ses investissements	AN
13/07	Zenith Energy investit à Rome ; hausse du chiffre d'affaires pour Concurrent	AN

Autres langues

19/08	WINNERS & LOSERS: Defence Holdings pares losses, explains investment
13/07	Zenith Energy in Rome buy; Concurrent revenue rises
13/07	Aptamer Group PLC Provides Earnings Guidance for the Fiscal Year 2026
08/07	Brave Bison earnings jump; Aptamer begins Ebola work
08/07	Aptamer Group to Develop Bundibugyo Ebola Virus Tests
25/06	Caspian reports progress; Arkle nears Erongo drilling
25/06	Aptamer Group PLC Delivers First AI-Generated Optimer Candidates And Advances Therapeutic Pipeline
08/06	Forgent option agreement to buy Mount Sholl project
08/06	Aptamer Group to Launch Research Project for Folic Acid Binders
23/04	WINNERS & LOSERS: Diales earnings rise; Mirriad warns of liquidation
14/04	Zentek Ltd.'s SubsidiaryTriera Biosciences Inc Executes Ontario Centres of Innovation Collaborate 2 Commercialize Agreement
31/03	UK Synthetic Binders Develop Aptamer Closes Retail Offer
31/03	Aptamer Group raises £4.5 million through placing, subscription & retail offer
26/03	LPA to meet consensus; Aptamer raises GBP4.28 million
26/03	EARNINGS AND TRADING: Pennpetro eyes Texas well restart as oil rises
26/03	Aptamer Raises GBP5 Million Via Share Placing, Subscription, Retail Offer
26/03	Aptamer Group raises £4.275 mln via placing and subscription at 0.6p per share
25/03	Aptamer reports "meaningful" first-half progress alongside fundraise
25/03	Aptamer Group PLC Reports Earnings Results for the Half Year Ended December 31, 2025
25/03	Aptamer Group to Raise GBP4 Million via Share Placement, Subscription, Retail Offer
18/03	Intuitive Investments notes Hui10 user growth
18/03	Aptamer Group, Radiopharmium Partner to Launch Targeted Radiopharmaceutical Program
17/02	Metir Completes Initial Technical Feasibility Work for Pathogen Detector Platform
17/02	Aptamer Group plc Announces Successful Completion of Phase 1 of its Collaboration with Metir plc
29/01	Aptamer Group Bags Optimer Development Orders, Receives Inaugural Licensing Fee